Gait Characteristics Harvested During a Smartphone-Based Self-Administered 2-Minute Walk Test in People with Multiple Sclerosis: Test-Retest Reliability and Minimum Detectable Change.

2-minute walk test MDC SEM gait multiple sclerosis smartphone test-retest reliability wearable sensors

Journal

Sensors (Basel, Switzerland)
ISSN: 1424-8220
Titre abrégé: Sensors (Basel)
Pays: Switzerland
ID NLM: 101204366

Informations de publication

Date de publication:
19 Oct 2020
Historique:
received: 13 08 2020
revised: 09 10 2020
accepted: 13 10 2020
entrez: 22 10 2020
pubmed: 23 10 2020
medline: 10 3 2021
Statut: epublish

Résumé

The measurement of gait characteristics during a self-administered 2-minute walk test (2MWT), in persons with multiple sclerosis (PwMS), using a single body-worn device, has the potential to provide high-density longitudinal information on disease progression, beyond what is currently measured in the clinician-administered 2MWT. The purpose of this study is to determine the test-retest reliability, standard error of measurement (SEM) and minimum detectable change (MDC) of features calculated on gait characteristics, harvested during a self-administered 2MWT in a home environment, in 51 PwMS and 11 healthy control (HC) subjects over 24 weeks, using a single waist-worn inertial sensor-based smartphone. Excellent, or good to excellent test-retest reliability were observed in 58 of the 92 temporal, spatial and spatiotemporal gait features in PwMS. However, these were less reliable for HCs. Low SEM% and MDC% values were observed for most of the distribution measures for all gait characteristics for PwMS and HCs. This study demonstrates the inter-session test-retest reliability and provides an indication of clinically important change estimates, for interpreting the outcomes of gait characteristics measured using a body-worn smartphone, during a self-administered 2MWT. This system thus provides a reliable measure of gait characteristics in PwMS, supporting its application for the longitudinal assessment of gait deficits in this population.

Identifiants

pubmed: 33086734
pii: s20205906
doi: 10.3390/s20205906
pmc: PMC7589972
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : This research was funded by F Hoffmann-La Roche Ltd, Basel, Switzerland.
ID : *

Références

J Clin Epidemiol. 2010 Jul;63(7):804-5; author reply 806
pubmed: 20399609
Gait Posture. 2012 Jun;36(2):316-8
pubmed: 22465705
Sensors (Basel). 2019 Dec 21;20(1):
pubmed: 31877760
J Chiropr Med. 2016 Jun;15(2):155-63
pubmed: 27330520
J Clin Epidemiol. 2009 Oct;62(10):1062-7
pubmed: 19230609
Ann Neurol. 2011 Feb;69(2):292-302
pubmed: 21387374
J Neurol. 2019 Dec;266(12):3022-3030
pubmed: 31493037
J Neuroeng Rehabil. 2005 Jul 29;2:22
pubmed: 16053523
Eur J Phys Rehabil Med. 2019 Aug;55(4):450-455
pubmed: 30311490
Med Eng Phys. 2015 Apr;37(4):400-7
pubmed: 25749552
J Neuroeng Rehabil. 2017 May 22;14(1):43
pubmed: 28532417
J Med Internet Res. 2019 Aug 30;21(8):e14863
pubmed: 31471961
J Rehabil Res Dev. 2016;53(5):599-610
pubmed: 27898161
J Neural Transm (Vienna). 2013 Oct;120(10):1459-62
pubmed: 24057507
Gait Posture. 2014 Mar;39(3):958-64
pubmed: 24405749
Neuromuscul Disord. 2019 Jul;29(7):514-516
pubmed: 31272741
J Electromyogr Kinesiol. 2003 Dec;13(6):569-73
pubmed: 14573371
QJM. 2004 Oct;97(10):671-6
pubmed: 15367738
IEEE J Biomed Health Inform. 2015 Jul;19(4):1356-61
pubmed: 26087505
Gait Posture. 2019 Jan;67:37-42
pubmed: 30269001
Gait Posture. 2011 May;34(1):111-8
pubmed: 21531139
Adv Ther. 2009 Dec;26(12):1043-57
pubmed: 20082242
PLoS One. 2017 Sep 25;12(9):e0184823
pubmed: 28945776
Gait Posture. 2012 Apr;35(4):573-8
pubmed: 22277368
Int J MS Care. 2011 Spring;13(1):4-14
pubmed: 24453700
Neurology. 1983 Nov;33(11):1444-52
pubmed: 6685237
Top Spinal Cord Inj Rehabil. 2012 Summer;18(3):273-81
pubmed: 23459394
Qual Life Res. 2001;10(7):571-8
pubmed: 11822790
Int J MS Care. 2018 Jul-Aug;20(4):158-163
pubmed: 30150899
PLoS One. 2018 May 1;13(5):e0196463
pubmed: 29715279
IEEE J Biomed Health Inform. 2016 May;20(3):838-847
pubmed: 25850097
PLoS One. 2017 Feb 8;12(2):e0171346
pubmed: 28178288
Mult Scler. 2012 Jan;18(1):98-107
pubmed: 21921070
J Appl Physiol (1985). 2014 Oct 1;117(7):738-44
pubmed: 25103964
J Neurol Phys Ther. 2011 Dec;35(4):164-9
pubmed: 22052130
Mult Scler. 2013 Nov;19(13):1784-91
pubmed: 23587605
Gait Posture. 2010 May;32(1):23-8
pubmed: 20363136

Auteurs

Alan K Bourke (AK)

Roche Pharma Research and Early Development, pRED Informatics, Roche Innovation Center Basel, F Hoffmann-La Roche Ltd., Grenzacherstrasse 124, 4070 Basel, Switzerland.

Alf Scotland (A)

Inovigate, Aeschenvorstadt 55, 4051 Basel, Switzerland.

Florian Lipsmeier (F)

Roche Pharma Research and Early Development, pRED Informatics, Roche Innovation Center Basel, F Hoffmann-La Roche Ltd., Grenzacherstrasse 124, 4070 Basel, Switzerland.

Christian Gossens (C)

Roche Pharma Research and Early Development, pRED Informatics, Roche Innovation Center Basel, F Hoffmann-La Roche Ltd., Grenzacherstrasse 124, 4070 Basel, Switzerland.

Michael Lindemann (M)

Roche Pharma Research and Early Development, pRED Informatics, Roche Innovation Center Basel, F Hoffmann-La Roche Ltd., Grenzacherstrasse 124, 4070 Basel, Switzerland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH